Published in Obesity and Diabetes Week, December 12th, 2005
Results from this study will form the basis of a supplemental New Drug Application submission to the Food and Drug Administration, currently planned for mid 2006.
A1C, a measure of glucose control over the previous 3 months, improved by approximately 0.9 percentage points at the end of the 16-week study for subjects receiving...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week